Back to Search
Start Over
Long-Term Response to Gefitinib and Crizotinib in Lung Adenocarcinoma Harboring Both Epidermal Growth Factor Receptor Mutation and EML4-ALK Fusion Gene
- Source :
- Journal of Clinical Oncology. 32:e30-e32
- Publication Year :
- 2014
- Publisher :
- American Society of Clinical Oncology (ASCO), 2014.
- Subjects :
- Cancer Research
Lung Neoplasms
EML4/ALK Fusion Gene
Oncogene Proteins, Fusion
Oncogene Proteins
Pyridines
Adenocarcinoma of Lung
Adenocarcinoma
medicine.disease_cause
Drug Administration Schedule
alk
Gefitinib
Crizotinib
Antineoplastic Combined Chemotherapy Protocols
Humans
Medicine
Molecular Targeted Therapy
Epidermal growth factor receptor
Protein Kinase Inhibitors
gefitinib
lung adenocarcinoma
Aged
Mutation
Lung
biology
business.industry
medicine.disease
ErbB Receptors
Treatment Outcome
medicine.anatomical_structure
Oncology
Disease Progression
Quinazolines
Cancer research
biology.protein
Pyrazoles
Female
business
medicine.drug
Subjects
Details
- ISSN :
- 15277755 and 0732183X
- Volume :
- 32
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Oncology
- Accession number :
- edsair.doi.dedup.....d96399c8a9cd51b81bcfae44508457f8